Lipid signaling: Sleep, synaptic plasticity, and neuroprotection

Prostaglandins and Other Lipid Mediators

Volumn 77, Issue 1-4 SPEC. ISS., 2005, Pages 65-76

  Chen, Chu ^a   Bazan, Nicolas G ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclooxygenase; Endocannabinoid; Long term potentiation; Neuroprotectin D1; Platelet activating factor; Polyunsaturated fatty acid; Prostaglandin E2; Sleep deprivation; Synaptic plasticity

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 4 AMINOBUTYRIC ACID; ARACHIDONIC ACID; CALCIMYCIN; CALCIUM; CANNABINOID RECEPTOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ENDOCANNABINOID; G PROTEIN COUPLED RECEPTOR; NEUROTRANSMITTER; OMEGA 3 FATTY ACID; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2; THROMBOCYTE ACTIVATING FACTOR;

4 AMINOBUTYRIC ACID RELEASE; ASTROCYTE; BRAIN FUNCTION; BRAIN ISCHEMIA; CALCIUM TRANSPORT; CELL MEMBRANE DEPOLARIZATION; CONFERENCE PAPER; DENTATE GYRUS; ENZYME SYNTHESIS; FACILITATION; HIPPOCAMPUS; HUMAN; LIPID BRAIN LEVEL; LONG TERM POTENTIATION; MEMORY CONSOLIDATION; MINIATURE ENDPLATE POTENTIAL; NERVE CELL PLASTICITY; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; PRESYNAPTIC MEMBRANE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; REM SLEEP; RETROGRADE NERVE FIBER TRANSPORT; SECOND MESSENGER; SLEEP INDUCTION; SLEEP WAKING CYCLE; SYNAPTIC TRANSMISSION;

ANIMALS; DINOPROSTONE; ENDOCANNABINOIDS; FATTY ACIDS; HIPPOCAMPUS; HUMANS; LIPID METABOLISM; MEMORY; MODELS, BIOLOGICAL; NEURONAL PLASTICITY; NEURONS; NEUROPROTECTIVE AGENTS; PLATELET ACTIVATING FACTOR; PROSTAGLANDIN D2; SIGNAL TRANSDUCTION; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 23644451669     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2005.07.001     Document Type: Conference Paper

References (63)

1. G.D. Clark, L.T. Happel, C.F. Zorumski, and N.G. Bazan Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor Neuron 9 1992 1211
2. K. Kato, G.D. Clark, N.G. Bazan, and C.F. Zorumski Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation Nature 367 1994 175
3. C. Chen, C.J. Magee, and N.G. Bazan Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity J Neurophysiol 87 2002 2851
4. C.M. McDermott, G.J. LaHoste, C. Chen, A. Musto, NG. Bazan, and J.C. Magee Sleep deprivation causes behavioral, synaptic, and membrane excitability alterations in hippocampal neurons J Neurosci 23 2003 9687
5. V.L. Marcheselli, S. Hong, and W.J. Lukiw Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression J Biol Chem 278 2003 43807
6. P.K. Mukherjee, V.L. Marcheselli, C.N. Serhan, and N.G. Bazan Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress Proc Nat Acad Sci USA 101 2004 8491
7. S.M. Reppert, and D.R. Weaver Coordination of circadian timing in mammals Nature 418 2002 935
8. K. Sakai, and S. Crochet A neural mechanism of sleep and wakefulness Sleep Biol Rhythm 1 2003 29
9. O. Hayaishi Molecular mechanisms of sleep-wake regulation: a role of prostaglandin D2 Philos Trans R Soc Lond B Biol Sci 355 2000 275
10. O. Hayaishi Functional genomics of sleep and circadian rhythm invited review: molecular genetic studies on sleep-wake regulation, with special emphasis on the prostaglandin D2 system J Appl Physiol 92 2002 863
11. B.F. Cravatt, O. Prospero-Garcia, and G. Siuzdak Chemical characterization of a family of brain lipids that induce sleep Science 268 1995 1506
12. R. Mechoulam, E. Fride, L. Hanuš, and T. Sheskin Anandamide may mediate sleep induction Nature 89 1997 25
13. E. Murillo-Rodŕiguez, M. Sánchez-Alavez, L. Navarro, Martínez-González, R. Drucker-Colín, and O. Prospéro-García Anandamide modulates sleep and memory in rats. Brain Res 812 1998 270
14. V. Santucci, J.J. Storme, and P. Soubrie Fur. Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SD141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis Life Sci 58 1996 103
15. M. Valenti, D. Viganò, and M.G. Cascio Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain Cell Mol Life Sci 61 2004 945
16. N. Stella, P. Schweitzer, and D. Piomelli A second endogenous cannabinoid that mediates long-term potentiation Nature 388 1997 773
17. N.G. Bazan Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activator J Lipid Res 44 2003 2221
18. S.M. Prescott, G.A. Zimmerman, D.M. Stafforini, and T.M. McIntyre Platelet-activating factor and related lipid mediators Annu Rev Biochem 69 2000 419
19. A. Wierazko, E. Knornecki, M.V. Hogan, and Y.H. Ehrlich Long-term potentiation in the hippocampus induced by platelet-activating factor Neuron 10 1993 553
20. K. Kato, and C.F. Zorumski Platelet-activating factor as a potential retrograde messenger J Lipid Med Cell Signal 14 1996 341
21. N.G. Bazan A signal terminator Nature 374 1995 501
22. C. Chen, J.C. Magee, V. Marcheselli, M. Hardy, and N.G. Bazan Attenuated long-term potentiation in hippocampal dentate gyrus neurons of mice deficient in the platelet-activating factor receptor J Neurophysiol 85 2001 384
23. I. Izquierdo, C. Fin, and P.K. Schmitz Memory enhancement by intrahippocampal, intraamygdala or intraentorhinal infusion of platelet-activating factor measured in an inhibitory avoidance Proc Natl Acad Sci USA 92 1995 5047
24. E. Kornecki, and Y.H. Ehrlich Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor Science 240 1988 1792
25. 2+ in hippocampal neurons Neuron 9 1992 285
26. J.R. Vane, and Y.S. Bakhle Botting RM. Cyclooxygenase 1 and 2 Annu Rev Pharmacol Toxicol 38 1998 97
27. N.V. Chandrasekharan, H. Dai, and Roos KLT COX-3, a Cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression Proc Natl Acad Sci USA 99 2002 13926
28. N.G. Bazan, and R.J. Flower Lipid signals in pain control Nature 420 2002 135
29. W.L. Smith, R.M. Garavito, and D.L. DeWitt Prostaglandin endoperoxide H synthases (cyclooxygenase)-1 and -2 J Biol Chem 271 1996 33157
30. R.N. Dubois, S.B. Abramson, L. Crofford, R.A. Gupta, and L.S. Simon Van de Putte LBA, Lipsky PE. Cyclooxygenase in biology and disease FASEB J 12 1998 1063
31. N.G. Bazan COX-2 as a multifunctional neuronal modulator Nature Medicine 7 2001 414
32. L. Ho, C. Pieroni, D. Winger, D.P. Purohit, P.S. Aisen, and G.M. Pasinetti Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease J Neurosci Res 57 1999 295
33. K. Yamagata, K.I. Andreasson, W.E. Kaufmann, C.A. Barnes, and P.F. Worley Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids Neuron 11 1993 371
34. S. Hewett, T.F. Uliasz, A.S. Vidwans, and J.A. Hewett Cyclooxygenase-2 contributes to N-methyl-d-aspartate-mediated neuronal cell death in primary cortical cell culture J Pharmacol Exp Ther 293 2000 417
35. C. Iadecola, K. Niwa, and S. Nogawa Reduced susceptibility to ischemic brain injury and N-methyl-d-aspartate-mediated neurotoxicity in cyclooxygenase-2 deficient mice Proc Natl Acad Sci USA 98 2001 1294
36. S. Miettinen, F.R. Fusco, and J. Yrjänheikki Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-d-aspartic acid-receptors and phospholipase A2 Proc Natl Acad Sci USA 94 1997 6500
37. M. Nakayama, K. Uchimura, and R.L. Zhu Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia Proc Natl Acad Sci USA 95 1998 10954 10959
38. W.E. Kaufmann, P.F. Worley, J. Pegg, M. Bremer, and P. Isakson COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex Proc Natl Acad Sci USA 93 1996 2317
39. P. Bezzi, G. Carmignoto, and L. Pasti Prostaglandins stimulate calcium-dependent glutamate release in astrocytes Nature 391 1998 281
40. M. Zonta, M.C. Angulo, and S. Gobbo Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation Nat Neurosci. 6 2003 43
41. Y. Boie, R. Stocco, and N. Sawyer Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes Eur J Pharmacol 340 1997 227
42. R.M. Breyer, C.K. Bagdassarian, S.A. Myers, and M.D. Breyer Prostanoid receptors: subtypes and signaling Annu Rev Pharmacol Toxicol 41 2001 661
43. S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid receptors: structure, properties, and functions Physiol Rev 79 1999 1193
44. S. Ahmadi, S. Lippross, W.L. Neuhuber, and H.U. Zeilhofer PGE2 selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons Nat Neurosci 5 2002 34
45. H. Baba, T. Kohno, K.A. Moore, and C.J. Woolf Direct activation of rat spinal dorsal neurons by prostaglandin E2 J Neurosci 21 2001 1750
46. K.R. Kozak, J.J. Prusakiewicz, and L.J. Marnett Oxidative metabolism of endocannabinoids by COX-2 Curr Pharmaceutical Design 10 2004 659
47. J. Kim, and B.E. Alger Inhibition of cyclooxygenases-2 potentiates retrograde endocannabinoid effects in hippocampus Nat Neurosci 7 2004 697
48. C.C. Felder Cannabinoid receptors and their endogenous agonists Annu Rev Pharmacol 38 1998 179
49. T.F. Freund, I. Katona, and D. Piomelli Role of endogenous cannabinoids in synaptic signaling Physiol Rev 83 2003 1017
50. S.D. McAllister, and M. Glass CB1 and CB2 receptor-mediated signaling: a focus on endocannabinoids Prostaglandins Leukot Essent Fatty Acid 66 2002 161
51. D. Piomelli The molecular logic of endocannabinoid signaling Nat Rev Neurosci 4 2003 873
52. T. Sugiura, S. Kishimoto, S. Oka, M. Gokoh, and K. Wake Metabolism and physiological significance of anandamide and 2-arachidonoylglycerol, endogenous cannabinoid receptor ligands N. Alfred Fonteh L. Robert Wykle Arachidonate remodeling and inflammation 2004 Birkhäuser Verlag Basel, Switzerland 211 237
53. R.I. Wilson, and R.A. Nicoll Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses Nature 410 2001 588
54. R.I. Wilson, and R.A. Nicoll Endocannabinoids signaling in the brain Science 296 2002 678
55. S.A. Deadwyler, R.E. Hampson, J. Mu, A. Whyte, and S.R. Childers Cannabinoids modulate voltage-sensitive potassium A current in hippocampal neurons via a cMP-dependent process J Pharmacol Exp Ther 273 1995 734
56. W. Twitchell, S. Brown, and K. Mackie Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons J Neurophysiol 78 1997 43
57. N. Hájos, I. katona, and S.S. Naiem Cannabinoids inhibit hippocampal GABAerigc transmission and network oscillations Eur J Neurosci 12 2002 3239
58. A.F. Hoffman, and C.R. Lupica Mechanisms of cannabinoid inhibition of GABAA synaptic transmission in the hippocampus J Neurosci 20 2000 2470
59. A.J. Irving, A.A. Coutts, and J. Harvey Functional expression of cell surface cannabinoid CB1 receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons Neuroscience 98 2000 253
60. G.A. Bohme, M. Laville, C. Ledent, M. Parmentier, and A. Imperato Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors Neuroscience 95 2000 5
61. J.M. Sullivan Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons J Neurophysiol 82 1999 1286
62. C.N. Serhan, K. Gotlinger, S. Hong, and M. Arita Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles on catabasis Prostaglandins Other Lipid Mediat 73 2004 155
63. C.N. Serhan, S. Hong, and K. Gotlinger Resolvins: a family of bioactive products of omega-3-fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation J Biol Chem 196 2002 1025